Delivery Order #SPE2D226F3051

Delivery Order for Ondansetron Hydrochloride under Indefinite Delivery Contract

This contract represents a delivery order awarded under an existing indefinite delivery contract held by DMS Pharmaceutical Group Inc., a prominent pharmaceutical manufacturer and distributor. The acquisition pertains specifically to the procurement of Ondansetron Hydrochloride, a medication commonly used to prevent nausea and vomiting caused by medical treatments. The award highlights the ongoing commitment of the contracting agency to secure essential pharmaceutical supplies that support government healthcare programs and public health initiatives. The scope of work includes the timely provision and delivery of this medication to Park Ridge, Illinois, reinforcing the reliable supply chain established by the broader contract. This delivery order is part of a competitively awarded, substantial indefinite delivery vehicle contract that commenced in mid-2025, demonstrating continued reliance on DMS Pharmaceutical Group for critical drug products. Although no subcontractors or prior related contracts are specified for this order, it contributes to a significant multi-year agreement aimed at ensuring consistent access to vital medications. The contract was recently awarded with a short-term performance period, ensuring prompt fulfillment of delivery requirements.

Description

8512245540!ONDANSETRON HYDROCH

View original record